Validation of a 5-year risk score of hip fracture in postmenopausal women. The Danish Nurse Cohort Study

Osteoporosis International

Volumn 21, Issue 12, 2010, Pages 2135-2142

  Hundrup, Y A ^a   Jacobsen, R K ^a   Andreasen, A H ^a   Davidsen, M ^b   Obel, E B ^c   Abrahamsen, B ^d,e  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Cohort study; Hip fracture risk score; Osteoporosis; Postmenopausal women; Validation study

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DECISION MAKING; DENMARK; DIAGNOSTIC VALUE; DISEASE REGISTRY; FEMALE; FOLLOW UP; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; NURSE; PERFORMANCE; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; WOMEN'S HEALTH;

AGED; ALGORITHMS; COHORT STUDIES; DENMARK; ESTROGEN REPLACEMENT THERAPY; FEMALE; HIP FRACTURES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 78549293051     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1176-7     Document Type: Article

References (23)

1. WHO Study Group 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis 843 1 129
2. B Gullberg O Johnell JA Kanis 1997 Worldwide projections for hip fracture Osteoporos Int 7 407 413 1:STN:280:DyaK1c%2Fos1Kgtg%3D%3D 10.1007/PL00004148 9425497 (Pubitemid 27443065)
3. JA Kanis O Johnell C De Laet B Jonsson A Oden AK Ogelsby 2002 International variations in hip fracture probabilities: implications for risk assessment J Bone Miner Res 17 1237 1244 10.1359/jbmr.2002.17.7.1237 12096837
4. P Vestergaard L Rejnmark L Mosekilde 2008 Strongly increasing incidence of hip fractures in Denmark from 1977 to 1999 Ugeskr Laeger 170 621 623 18367043
5. SR Cummings MC Nevitt WS Browner K Stone CS Fox K Ensrud JA Cauley D Black TM Voght 1995 Risk factors for hip fracture in white women N Engl J Med 332 767 773 1:STN:280:DyaK2M7ms1aktw%3D%3D 10.1056/NEJM199503233321202 7862179
6. NE Lane 2006 Epidemiology, etiology, and diagnosis of osteoporosis Am J Obstet Gynecol 194 S3 S11 1:CAS:528:DC%2BD28XhtVamtLk%3D 10.1016/j.ajog.2005.08. 047 16448873 (Pubitemid 43152482)
7. JA Cauley LL Wu NS Wampler JM Barnhart M Alison Z Chen R Jackson J Robbins 2007 Clinical risk factors for fractures in multi-ethnic women: the women's health initiative J Bone Miner Res 22 1816 1826 10.1359/jbmr.070713 17638574 (Pubitemid 351235149)
8. MT Hannan DT Felson B Dawson-Hughes KL Tucker LA Cupples PWF Wilson DP Kiel 2000 Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study J Bone Miner Res 15 710 720 1:STN:280: DC%2BD3c3ktFOktw%3D%3D 10.1359/jbmr.2000.15.4.710 10780863
9. DM Black M Steinbuch L Palermo P Dargent-Molina R Lindsay MS Hoseyni O Johnell 2001 An assessment tool for predicting fracture risk in postmenopausal women Osteoporosis Int 12 519 528 1:STN:280:DC%2BD3MvosFagtQ%3D%3D 10.1007/s001980170072 (Pubitemid 32777427)
10. DS Buist A Lacroix D Manfredonia T Abbott 2002 Identifying postmenopausal women at high risk of fracture in populations: a comparison of three strategies J Am Geriatr Soc 50 1031 1038 10.1046/j.1532-5415.2002.50257.x 12110062 (Pubitemid 34666308)
11. SM Cadarette SB Jaglal TM Murray WJ Mclsaac L Joseph JP Brown Canadian Multicentre Osteoporosis Study (CaMos) 2001 Evaluation of decision rules for referring women for bone densitometry by dual-energy X-ray absorptiometry JAMA 286 57 63 1:STN:280:DC%2BD3MvgtFeruw%3D%3D 10.1001/jama.286.1.57 11434827
12. CW McGrother MMK Donaldson D Clayton KR Abrams M Clarke 2002 Evaluation of a hip fracture risk score for assessing elderly women: the Melton Osteoporotic Fracture (MOF) Study Osteoporos Int 13 89 96 1:STN:280: DC%2BD387ltFSqtA%3D%3D 10.1007/s198-002-8343-6 11883411 (Pubitemid 34157836)
13. PD Miller S Barlas SK Brenneman TA Abott Y Chen EL Barrett-Connor ES Siris 2004 An approach to identifying osteopenic women at increased short-term risk of fracture Arch Intern Med 164 1113 1120 10.1001/archinte.164.10.1113 15159269 (Pubitemid 38668991)
14. AM Schott C Ganne D Hans G Monnier R Gauchoux MA Krieg PD Delmas PJ Meunier C Colin 2007 Which screening strategy using BMD measurements would be most cost effective for hip fracture prevention in elderly women? Osteoporos Int 18 143 151 1:STN:280:DC%2BD2s7ivVenug%3D%3D 10.1007/s00198-006-0227-6 17039393 (Pubitemid 46091623)
15. JE Rossouw GL Anderson RL Prentice AZ LaCroix C Kooperberg ML Stefanik RD Jackson SA Beresford BV Howard KC Johnson JM Kotchen J Ockene Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative. Randomized controlled trial JAMA 288 321 333 1:CAS:528:DC%2BD38Xltlegs7k%3D 10.1001/jama.288.3.321 12117397
16. J Robbins AK Aragaki C Kooperberg N Watts J Wactawski-Wende RD Jackson MS LeBoff CE Lewis Z Chen ML Stefanick JA Cauley 2007 Factors associated with 5-year risk of hip fracture in postmenopausal women JAMA 298 2389 2398 1:CAS:528:DC%2BD2sXhtlyjtLrM 10.1001/jama.298.20.2389 18042916 (Pubitemid 350190780)
17. YA Hundrup S Høidrup O Ekholm M Davidsen EB Obel 2004 Risk of low-energy hip, wrist, and upper arm fractures among current and previous users of hormone replacement therapy. The Danish Nurse Cohort Study Eur J Epidemiol 19 1089 1095 10.1007/s10654-004-2173-y 15678788 (Pubitemid 40228497)
18. YA Hundrup O Ekholm S Høidrup M Davidsen EB Obel 2005 Risk factors for hip fracture and a possible effect modification by hormone replacement therapy. The Danish Nurse Cohort Study Eur J Epidemiol 19 1089 1095 10.1007/s10654-004-2173-y
19. ME Miller S Hui WM Tierney 1991 Validation techniques for logistic regression models Stat Med 10 1213 1226 1:STN:280:DyaK38%2FitF2rsA%3D%3D 10.1002/sim.4780100805 1925153
20. D Black PD Delmas R Eastell IR Reid S Boonen JA Cauley F Cosman P Lakatos PC Leung Z Man C Mautalen P Mesenbrink H Hu J Caminis K Tong T Rosatio-Jansen J Krasnow TF Hue D Sellmeyer EF Eriksen S Cummings The Horizon Pivotal Fracture Trial 2007 Once yearly zoledronic acid for treatment of postmenopausal osteoporosis N Engl J Med 356 1809 1821 1:CAS:528:DC%2BD2sXltVSktLc%3D 10.1056/NEJMoa067312 17476007 (Pubitemid 46698462)
21. T-P van Staa JP Kanis P Geussens A Boonen HGM Leufkens C Cooper 2007 The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks Value Health 10 348 357 10.1111/j.1524-4733. 2007.00188.x 17888099 (Pubitemid 47481106)
22. JA Kanis A Oden O Johnell H Johansson C De Laet J Brown P Burckardt C Cooper C Christiansen S Cummings JA Eisman S Fujiwara C Glüer D Goltzman D Hans MA Krieg A Lacroix E McCloskey D Mellstrom LJ Melton III H Pols J Reeve K Sanders A-M Schott A Silman D Torgerson T-P van Staa NB Watts N Yoshimura 2007 The use of clinical risk factors enhances the performance of BMD in prediction of hip and osteoporotic fractures in men and women Osteoporos Int 18 1046 10.1007/s00198-007-0343-y (Pubitemid 47020000)
23. E Seeman J-P Devogelaer R Lorence T Spector K Brixen A Balogh G Stucki J-Y Reginster 2008 Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia J Bone Miner Res 23 433 438 1:CAS:528: DC%2BD1cXjsl2itbo%3D 10.1359/jbmr.071105 17997711 (Pubitemid 351304674)